This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimers disease
Investments > €500k
European Commission
Alzheimer’s disease & other dementias
2016
